How to save a life with naloxone
By providing non-judgemental and appropriate counselling on the use of naloxone, pharmacists can empower those who carry it to confidently intervene in the case of opioid toxicity.
Neuropathic pain medicines can increase the risk of falls
These oft-used medicines have become the analgesia of choice for many prescribers. But care should be taken before prescribing gabapentinoids to certain patients.
Gabapentinoid medicines...
Date of birth now required on all NSW scripts
From 1 November 2022, the date of birth of every patient must be included on all prescriptions for Schedule 4 and Schedule 8 medicines.
Government pulls the plug on replica Ozempic
After much media scrutiny, the federal Department of Health and Aged Care has announced a ban on compounded GLP-1RAs.
Australia’s most poisonous drug: paracetamol
Paracetamol overdose is both common and complex. But pharmacists have the power to curb the risk of overdose.
Active Ingredient Prescribing grace period comes to an end
A new wave of private prescriptions may be approaching, as the Active Ingredient Prescribing (AIP) grace period comes to an end.














